Cardiac organ donor management

Perfusion

Volumn 21, Issue 2, 2006, Pages 93-98

  Ullah, Sana ^a   Zabala, Luis ^a   Watkins, Bryan ^a   Schmitz, Michael L ^a  

^a ARKANSAS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; DESMOPRESSIN; DOPAMINE; INOTROPIC AGENT; INSULIN; LIOTHYRONINE; METHYLPREDNISOLONE; OXYGEN; THYROXINE; VASOPRESSIN;

ANAEROBIC METABOLISM; ANEMIA; ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD VOLUME; BRAIN DEATH; CARDIOPULMONARY HEMODYNAMICS; CLINICAL TRIAL; DIABETES INSIPIDUS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ECHOCARDIOGRAPHY; ENDOCRINE DISEASE; HEALTH CARE ORGANIZATION; HEART FUNCTION; HEART MUSCLE INJURY; HEART TRANSPLANTATION; HEART VENTRICLE FUNCTION; HEMATOLOGIC DISEASE; HEMODYNAMICS; HUMAN; HYPOTENSION; HYPOTHYROIDISM; HYPOVOLEMIA; INJURY; LUNG FUNCTION; LUNG VENTILATION; METABOLIC DISORDER; ORGAN DONOR; OXYGEN TRANSPORT; PATIENT MONITORING; PRIORITY JOURNAL; RESPIRATORY SYSTEM; RESUSCITATION; RETROSPECTIVE STUDY; SHOCK; THERMOREGULATION; UNITED KINGDOM;

HEART TRANSPLANTATION; HUMANS; RETROSPECTIVE STUDIES; TISSUE DONORS;

EID: 33645774966     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1191/0267659106pf851oa     Document Type: Article

References (36)

1. 3 OPTN/SRTR Annual Report. Retrieved from http://www.optn.org
2. Novitzky D, Wicomb WN, Cooper DKC, Rose AG, Fraser RC, Barnard CN. Electrocardiographic, hemodynamic and endocrine changes occurring during experimental brain death in the Chacma baboon. J Heart Transplant 1984; 4: 13-19.
3. Novitzky D, Horak A, Cooper DK et al. Electrocardiographic and histopathologic changes developing during experimental brain death in the baboon. Transplant Proc 1989; 21(1): 2567-69.
4. Wilhelm MJ, Pratschke J, Beato F et al. Activation of the heart by donor brain death accelerates rejection after transplantation. Circulation 2000; 102: 2426-33.
5. Mehra MR, Uber PA, Ventura HO, Scott RL, Park MH. The impact of mode of brain death on cardiac allograft vasculopathy. J Am Coll Cardiol 2004; 43: 806-10.
6. Cantin B, Kwok BWK, Chan MCY et al. The impact of brain death on survival after heart transplantation: time is of the essence. Transplantation 2003; 76: 1275-79.
7. Segel LD, vonHaag DW, Zhang J, Follette DM. Selective overexpression of inflammatory molecules in hearts from brain-dead rats. J Heart Lung Transplant 2002; 21: 804-11.
8. Szabo G, Buhmann V, Sebening C et al. Brain death impairs coronary endothelial dysfunction. Transplantation 2002; 73: 1846-48.
9. Anyanwu AC, Banner NR, Mitchell AG, Khagani A, Yacoub MH. Low incidence and severity of transplant-associated coronary artery disease in heart transplants from live donors. J Heart Lung Transplant 2003; 22: 281-86.
10. Sztark F, Thicoipe M, Lassie P et al. Mitochondrial energy metabolism in brain-dead organ donors. Ann Transplant 2000; 5: 41-44.
11. Novitzky D, Cooper DK, Morrell D, Isaacs S. Change from aerobic to anaerobic metabolism after brain death, and reversal following triiodothyronine therapy. Transplantation 1988; 45: 32-36.
12. Klein I, Ojamaa K. Mechanisms of disease: thyroid hormone and the cardiovascular system. N Engl J Med 2001; 344: 501-509.
13. Holland FW II, Brown PD Jr, Weintraub BD et al. Cardiopulmonary bypass and thyroid function: a 'euthyroid sick syndrome'. Ann Thorac Surg 1991; 52: 46-50.
14. Klemperer JD, Klein I, Gomez M et al. Thyroid hormone treatment after coronary-artery bypass surgery. N Engl J Med 1995; 333:1522-27.
15. Bettendorf M, Schmidt KG, Tiefenbacher U et al. Transient secondary hypothyroidism in children after cardiac surgery. Pediatr Res 1997; 41: 375-79.
16. Mainwaring RD, Healey RM, Meier FA et al. Reductions in levels of triiodothyronine following the first stage of the Norwood reconstruction for hypoplastic left heart syndrome. Cardiol Young 2001; 11: 295-300.
17. McMahon CK, Klein I, Ojamaa K. Interleukin-6 and thyroid hormone metabolism in pediatric cardiac surgery patients. Thyroid 2003; 13: 301-304.
18. Bettendorf M, Schmidt KG, Grulich-Henn J et al. Triiodothyronine treatment in children after cardiac surgery: a double-blind, randomized, placebo-controlled study. Lancet 2000; 356: 529-34.
19. Utiger RD. Altered thyroid function in nonthyroidal illness and surgery. To treat or not to treat? [Editorial]. N Engl J Med 1995; 333: 1562-63.
20. Stathatos N, Levetan C, Burman KD, Wartofsky L. The controversy of the treatment of critically ill patients with thyroid hormone. Best Pract Res Clin Endocrinol Metab 2001; 15: 465-78.
21. Novitzky D, Cooper DKC, Chaffin JS et al. Improved cardiac allograft function following triiodothyronine therapy to both donor and recipient. Transplantation 1990; 49: 311-16.
22. Jeevanandam V, Todd B, Regillo T et al. Reversal of donor myocardial dysfunction by triiodothyronine replacement therapy. J Heart Lung Transplant 1994; 13: 681-87.
23. Zuppa AF, Nadkarni V, Davis L et al. The effect of thyroid hormone infusion on vasopressor support in critically ill children with cessation of neurologic function. Crit Care Med 2004; 32: 2318-22.
24. Salim A, Vassiliu P, Velmahos GC et al. The role of thyroid hormone administration in potential organ donors. Arch Surg 2001; 136: 1377-80.
25. Goarin JP, Cohen S, Riou B et al. The effect of triiodothyronine on hemodynamic status and cardiac function in potential heart donors. Anesth Analg 1996; 83: 41-47.
26. Wheeldon DR, Potter CDO, Oduro A, Wallwork J, Large SR. Transforming the 'unacceptable' donor: outcomes from the adoption of a standardized donor management technique. J Heart Lung Transplant 1995; 14: 734-42.
27. Zaroff JG, Rosengard BR, Armstrong WF et al. Consensus conference report. Maximizing use of organs recovered from the cadaver donor: cardiac recommendations. Circulation 2002; 106: 836-41.
28. Critical pathway for the organ donor. Retrieved from http://www.unos.org
29. Rosendale JD, Chabalewski FL, McBride MA et al. Increased transplanted organs from the use of a standardized donor management protocol. Am J Transplant 2002; 2: 761-68.
30. Katz K, Lawler J, O'Connor R, Nadkarni V. Vasopressin pressor effects in critically ill children during evaluation for brain death and organ recovery. Resuscitation 2000; 47: 33-40.
31. Pennefather SH, Bullock RE, Mantle RE et al. Use of low dose arginine vasopressin to support brain dead organ donors. Transplantation 1995; 59: 58-62.
32. Stoica SC, Satchitananda DK, White PA, Parameshwar J, Redington AN, Large SR. Noradrenaline use in the human donor and relationship with load-independent right ventricular contractility. Transplantation 2004; 78: 1193-97.
33. Sypniewski E. Comparative pharmacology of thyroid hormones. Ann Thorac Surg 1993; 56: S2-S8.
34. Mainwaring RD, Capparelli E, Schell K, Acosta M, Nelson JC. Pharmacokinetic evaluation of triiodothyronine supplementation in children after modified Fontan procedure. Circulation 2000; 101: 1423-29.
35. Rosendale JD, Kauffman HM, McBride MA et al. Aggressive pharmacologic donor management results in more transplanted organs. Transplantation 2003; 75: 482-87.
36. Rosendale JD, Kauffman HM, McBride MA et al. Hormonal resuscitation yields more transplanted hearts, with improved early function. Transplantation 2003; 75: 1336-41.